Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2019

Oct 24, 2019

SELL
$90.37 - $122.49 $632,590 - $857,430
-7,000 Closed
0 $0
Q2 2019

Aug 02, 2019

SELL
$89.51 - $118.04 $707,129 - $932,516
-7,900 Reduced 53.02%
7,000 $241,000
Q1 2019

Apr 29, 2019

BUY
$61.98 - $96.5 $508,236 - $791,300
8,200 Added 122.39%
14,900 $156,000
Q3 2018

Oct 15, 2018

BUY
$48.29 - $80.6 $24,145 - $40,300
500 Added 8.06%
6,700 $36,000
Q2 2018

Jul 09, 2018

SELL
$37.84 - $69.96 $113,520 - $209,879
-3,000 Reduced 32.61%
6,200 $28,000
Q1 2018

May 01, 2018

BUY
$39.82 - $57.53 $322,542 - $465,993
8,100 Added 736.36%
9,200 $15,000
Q4 2017

Feb 06, 2018

BUY
$46.49 - $60.51 $51,139 - $66,561
1,100
1,100 $6,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Center Star Asset Management, LLC Portfolio

Follow Center Star Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Center Star Asset Management, LLC with notifications on news.